BXPLANT is a premier Clinical Development and Research Organization (CDRO) that integrates R&D Bridging-based strategic development to ensure both scientific and commercial success.

1. Strategic R&D Bridging: 
We optimize "bench-to-bedside" pathways by validating non-clinical data for clinical continuity, significantly reducing development timelines and expenditure.

2. The 'Extreme Team': 
Led by subject matter experts with 15+ years of cross-functional experience—spanning clinical operations, medical writing, data management, biostatistics, and Regulatory Science—we provide high-impact study designs and accelerated clinical execution to streamline drug development.

3. MIDD & Full-Scope Consulting: 
Utilizing Model-Informed Drug Development (MIDD) to enhance Probability of Success (PoS), we offer end-to-end lifecycle management from initial R&D to Post-Market Surveillance (PMS).

4. Global MRCT & Commercialization: 
With a robust track record in Multi-Regional Clinical Trials, we provide cost-effective solutions prioritizing global market access and economic efficiency.

5. CVC & Acceleration Hub: 
Operating as a bio-specialized Corporate Venture Capital (CVC), we drive portfolio "Value-up" through a synergistic ecosystem of technical validation (CDRO) and strategic investment.

BXPLANT Co., Ltd.

Org chart

Teams

Offices